Mancuso M, Filosto M, Forli F, Rocchi A, Berrettini S, Siciliano G, Murri L
Department of Neurosciences, Neurological Clinics, University of Pisa, Pisa, Italy.
Acta Neurol Scand. 2004 Jul;110(1):72-4. doi: 10.1111/j.1600-0404.2004.00254.x.
We described a patient with progressive non-syndromic hearing loss (NSHL) harboring the A3243G mutation in the mitochondrial DNA (mtDNA). Muscle biopsy showed scattered ragged-red, cytochrome c oxidase negative fibers, whereas the biochemical analysis of the mitochondrial respiratory chain complexes was normal. Restriction fragment length polymorphism (RFLP) analysis showed A3243G mtDNA transition, present at very low in patient's muscle (3%) and in urinary sediments (1%), and not detectable in blood and buccal mucosa. The patient was submitted to a bilateral cochlear implantation with post-operative excellent hearing and communicative outcomes. Our findings indicate that A3243G mutation may be responsible both for SHL and NSHL, may be depending on the levels of mutated mtDNA. Patients with hearing loss due to mtDNA mutations should be considered as good candidates for cochlear implantation.
我们描述了一名患有进行性非综合征性听力损失(NSHL)的患者,其线粒体DNA(mtDNA)存在A3243G突变。肌肉活检显示散在的破碎红、细胞色素c氧化酶阴性纤维,而线粒体呼吸链复合物的生化分析正常。限制性片段长度多态性(RFLP)分析显示A3243G mtDNA转变,在患者肌肉中含量极低(3%),在尿沉渣中为1%,在血液和口腔黏膜中未检测到。该患者接受了双侧人工耳蜗植入,术后听力和交流效果良好。我们的研究结果表明,A3243G突变可能是SHL和NSHL的病因,可能取决于突变mtDNA的水平。因mtDNA突变导致听力损失的患者应被视为人工耳蜗植入的良好候选者。